Skip to content
Laidlaw & Company Logo
  • Home
  • About Us
    • Team
  • Company History
  • Transactions
  • News
  • Client Login
    • Schwab
    • StoneX (formerly INTLFC Stone)
  • Wealth Management
  • Capital Markets
    • Capital Markets Team
    • Case Studies
    • Equity Research
  • Lucius Partners
  • Alternative Investments
  • Contact
Aldeyra Therapeutics TimelineJustin Rampley2023-12-18T04:18:48-05:00
Back to Case Studies
Site Info

Home
Contact Us
Company History

Legal

Terms and Conditions
Legal Information
Privacy Policy
Glossary
Record of Processing Activities
GDPR Rights Exercise Form

Disclosures

FINRA
SIPC
FCA
Business Continuity Plan Disclosure
Brokercheck
REGBI
StoneX Annual Disclosure
Options Disclosure Booklet

Contact Info
  • 521 5th. Ave. 12th Fl. New York, NY 10175
  • 212.697.5200

  • info@laidlawltd.com

© 2024 Copyright Laidlaw & Company (UK) Ltd. – All Rights Reserved. Laidlaw & Company (UK) Ltd., a FINRA broker-dealer registered in the United States, clears on a fully-disclosed basis through StoneX, a member of the Securities Investor Protection Corporation (SIPC). Laidlaw & Company International Limited is authorized and regulated by the Financial Conduct Authority (FCA) in the UK (Firm Reference No: 537165).

© Copyright 2023 Laidlaw & Company (UK) Ltd. - All Rights Reserved. Laidlaw & Company (UK) Ltd., a FINRA broker-dealer registered in the United States, clears on a fully-disclosed basis through INTL FCStone Financial Inc., a member of the Securities Investor Protection Corporation (SIPC). Laidlaw & Company International Limited is authorized and regulated by the Financial Conduct Authority (FCA) in the UK (Firm Reference No: 537165).

Close Sliding Bar Area

Recent Posts

  • Laidlaw’s James Ahern Named to Crain’s New York Notable Leaders in Finance 2024
  • EyePoint Pharmaceuticals Announces Closing of Upsized Public Offering and Full Exercise of Option to Purchase Additional Shares
  • Laidlaw served as Co-Manager on the $129,000,000 Common Stock and Concurrent Private Placement for Soleno Therapeutics (SLNO)

Stay In Touch

Contact Info

9876 West Green Street

Phone: 1-800-987-6543

Mobile: 1-800-345-6789

Email: info@your-domain.com

Web: Avada WP Theme

Page load link

You are now leaving Laidlaw & Company (UK) Ltd.

This link to the Private Stakes Program is provided as a service to Members, Clients and interested parties and will direct you to a third-party site independent of Laidlaw & Company (UK) Ltd.

Neither Laidlaw & Company (UK) Ltd. nor Laidlaw Private Equity, LLC own or manage the Private Stakes Program alternative investment vehicles. They are not responsible for the content of the site and do not guarantee the accuracy or completeness of any information or material contained therein.

Associated persons of Laidlaw & Company (UK) Ltd. and Laidlaw Private Equity, LLC are involved in the management and administration of each alternative investment vehicle described in the Private Stakes Program website.

Visit Private Stakes Program
Go to Top